Wang XY - Search Results

1

Immunotherapy of cancer: reprogramming tumor-immune crosstalk.

Payne KK, Toor AA, Wang XY, Manjili MH. Payne KK, et al. Among authors: wang xy. Clin Dev Immunol. 2012;2012:760965. doi: 10.1155/2012/760965. Epub 2012 Oct 11. Clin Dev Immunol. 2012. PMID: 23097673 Free PMC article. Review.

2

Immunotherapy of cancer using heat shock proteins.

Manjili MH, Wang XY, Park J, Facciponte JG, Repasky EA, Subjeck JR. Manjili MH, et al. Among authors: wang xy. Front Biosci. 2002 Jan 1;7:d43-52. doi: 10.2741/manjili. Front Biosci. 2002. PMID: 11779704 Review.

3

Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.

Manjili MH, Henderson R, Wang XY, Chen X, Li Y, Repasky E, Kazim L, Subjeck JR. Manjili MH, et al. Among authors: wang xy. Cancer Res. 2002 Mar 15;62(6):1737-42. Cancer Res. 2002. PMID: 11912148

4

Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.

Wang XY, Li Y, Manjili MH, Repasky EA, Pardoll DM, Subjeck JR. Wang XY, et al. Cancer Immunol Immunother. 2002 Aug;51(6):311-9. doi: 10.1007/s00262-002-0287-1. Epub 2002 Jun 13. Cancer Immunol Immunother. 2002. PMID: 12111119 Free PMC article.

5

Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.

Wang XY, Chen X, Manjili MH, Repasky E, Henderson R, Subjeck JR. Wang XY, et al. Cancer Res. 2003 May 15;63(10):2553-60. Cancer Res. 2003. PMID: 12750279

6

HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.

Manjili MH, Wang XY, Chen X, Martin T, Repasky EA, Henderson R, Subjeck JR. Manjili MH, et al. Among authors: wang xy. J Immunol. 2003 Oct 15;171(8):4054-61. doi: 10.4049/jimmunol.171.8.4054. J Immunol. 2003. PMID: 14530326

7

Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins.

Wang XY, Manjili MH, Park J, Chen X, Repasky E, Subjeck JR. Wang XY, et al. Methods. 2004 Jan;32(1):13-20. doi: 10.1016/s1046-2023(03)00181-6. Methods. 2004. PMID: 14624871

8

Cancer immunotherapy and heat-shock proteins: promises and challenges.

Manjili MH, Wang XY, MacDonald IJ, Arnouk H, Yang GY, Pritchard MT, Subjeck JR. Manjili MH, et al. Among authors: wang xy. Expert Opin Biol Ther. 2004 Mar;4(3):363-73. doi: 10.1517/14712598.4.3.363. Expert Opin Biol Ther. 2004. PMID: 15006730 Review.

9

Heat shock proteins HSP70 and GP96: structural insights.

Facciponte JG, Wang XY, MacDonald IJ, Park JE, Arnouk H, Grimm MJ, Li Y, Kim H, Manjili MH, Easton DP, Subjeck JR. Facciponte JG, et al. Among authors: wang xy. Cancer Immunol Immunother. 2006 Mar;55(3):339-46. doi: 10.1007/s00262-005-0020-y. Epub 2005 Jul 20. Cancer Immunol Immunother. 2006. PMID: 16032399 Free PMC article. Review.

10

Heat shock proteins and scavenger receptors: role in adaptive immune responses.

Facciponte JG, MacDonald IJ, Wang XY, Kim H, Manjili MH, Subjeck JR. Facciponte JG, et al. Among authors: wang xy. Immunol Invest. 2005;34(3):325-42. doi: 10.1081/imm-200064505. Immunol Invest. 2005. PMID: 16136784 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,856 results

Search Page